Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
Bansi P Savaliya, Ramin Shekouhi, Fatima Mubarak, Harsheen K Manaise, Paola Berrios Jimenez, Gabrielle Kowkabany, Reed A Popp, Kyle Popp, Emmanuel Gabriel
Bansi P Savaliya, Department of Surgery, Medical Academy Named after SI Georgievsky of Vernadsky Crimean Federal University, Simferopol 295015, Crimea, Russia
Ramin Shekouhi, Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Florida, Gainesville, FL 32608, United States
Fatima Mubarak, Department of Surgery, Aga Khan University, Karachi 74800, Sindh, Pakistan
Harsheen K Manaise, Department of Surgery, Government Medical College and Hospital, Chandigarh 160030, Punjab, India
Paola Berrios Jimenez, Department of Surgery, University of Puerto Rico School of Medicine, San Juan 00921, Puerto Rico
Gabrielle Kowkabany, Department of Chemical and Biological Engineering, University of Alabama, Tuscaloosa, AL 35487, United States
Reed A Popp, Department of Surgery, University of Florida College of Medicine, Gainesville, FL 32610, United States
Kyle Popp, Department of Surgery, Florida State University, Tallahassee, FL 32306, United States
Emmanuel Gabriel, Department of Surgery, Mayo Clinic, Jacksonville, FL 32224, United States
Author contributions: Savaliya BP designed the overall concept and outline of the manuscript; Shekouhi R, Mubarak F, Manaise HK, Jimenez PB, Kowkabany G, Popp RA, and Popp K contributed to the design of the manuscript; Savaliya BP, Shekouhi R, Mubarak F, Manaise HK, Jimenez PB, Kowkabany G, Popp RA, Popp K, and Gabriel EM contributed to the writing, editing, and review of literature.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Bansi P Savaliya, MD, Doctor, Department of Surgery, Medical Academy Named after SI Georgievsky of Vernadsky Crimean Federal University, 5/7 Lenina Blvd, Simferopol 295015, Crimea, Russia. bansisavaliya33@gmail.com
Received: April 2, 2024
Revised: May 10, 2024
Accepted: May 30, 2024
Published online: June 28, 2024
Processing time: 83 Days and 13.3 Hours
